Search

everythinglearnresearchcommunity

for

Search:↓

Atopic dermatitis increases the risk of some autoimmune diseases.

Most patients with dermatomyositis had skin rash, itching, and muscle weakness, treated mainly with prednisolone and hydroxychloroquine.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Careful diagnosis and management of MCTD are crucial due to potential severe complications.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Men with systemic lupus erythematosus often have more severe symptoms but can respond well to treatment.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

Social media can help compare the effectiveness and safety of new arthritis medications.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Low dose methotrexate does not increase hair fall and may reduce it.

The polyherbal emulgel is a promising treatment for rheumatoid arthritis with effective and sustained results.

Baricitinib improved hair loss and arthritis in a lupus patient.

A single dose of Platelet Rich Plasma effectively reduces symptoms of early knee osteoarthritis.

Pincer nails are rare in lupus patients and may be managed conservatively.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

PRP injections improve knee function in osteoarthritis.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Oral ulcers are common in SLE patients and often link to other symptoms.

Nonpharmaceutical Traditional Chinese Medicine therapies for rheumatoid arthritis have been increasingly researched over the past 20 years.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.